# CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL

> **NIH NIH N01** · ALBANY MOLECULAR RESEARCH, INC. · 2024 · $280,124

## Abstract

The overall objective of this project is for the contractor to support the chemistry, manufacturing, and controls (CMC) development of NCGC00413972 for preclinical safety evaluation and clinical trial.

## Key facts

- **NIH application ID:** 11140931
- **Project number:** 271201700005I-P00001-759502300001-1
- **Recipient organization:** ALBANY MOLECULAR RESEARCH, INC.
- **Principal Investigator:** BRIAN PENNY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $280,124
- **Award type:** —
- **Project period:** 2023-09-30 → 2027-09-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11140931

## Citation

> US National Institutes of Health, RePORTER application 11140931, CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL (271201700005I-P00001-759502300001-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11140931. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*